RUSSE / Russian Spiriva® Safety & Efficacy Study
Phase of Trial: Phase IV
Latest Information Update: 11 Jun 2014
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms RUSSE
- Sponsors Boehringer Ingelheim
- 20 Jan 2010 Actual number of patients (407) added as reported by ClinicalTrials.gov record.
- 29 Feb 2008 New trial record.